As of 2025-11-04, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (16.52) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -494.4%.
The range of the Relative Valuation is (15.66) - (19.07) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 14.4x | 12.8x |
| Forward P/E multiples | 8.0x - 13.6x | 10.8x |
| Fair Price | (15.66) - (19.07) | (16.52) |
| Upside | -473.7% - -555.2% | -494.4% |
| Date | P/E |